Tag:
genetic sequencing
Latest Headlines
Latest Headlines
Three studies back notion of autism erupting from genetic mutations
Three new studies appear to reinforce the idea that autism is connected to genetic mutations, at least in a subset of patients with the condition.
Genetic sequencing price tag plunging
Genetic sequencing costs are dropping at an accelerated velocity, and an article by the NYT predicts that their increased affordability will finally bring personalized medicine into everyday medical care.
Roche displays patience with Illumina bid
After all the fanfare behind Roche's ( $RHHBY ) $5.7 billion hostile bid for gene sequencing company Illumina ( $ILMN ), it looks as if the company will have to dig in for a pretty long fight. As Reuters
Fred Hutch sequencing project unveils key triggers for prostate cancer
Some researchers at the prestigious Fred Hutchinson Cancer Research Center allied with scientists at the University of Washington have helped illustrate just how significant sequencing can be for
Sequencing leaders want industry standards to govern decoded DNA
The math on sequencing's growing reach is pretty simple. In 2009, a few dozen genomes were sequenced. Last year the genes of some 1,700 people were sequenced. This year, analysts say the number will
Researchers, companies quick to crack E. coli case
The deadly E. coli outbreak in Europe has at least given biotech companies and researchers a reason to brag about their roles in helping to identify the strain responsible with press releases and
Next-gen gene sequencing for the price of a sandwich
New enterprises have been racing toward the $1,000 gene sequencing goal as new technology makes it simpler and less expensive to explore an individual's DNA and unlock specific disease triggers. Now
Progress reported in 1,000 Genome Project
We mentioned the 1,000 Genome Project in reference to a Japanese man who joined the exclusive club of those who have had their genetic code completely sequenced. Now more news organizations are
Roche, IBM team up on sequencing breakthrough
Roche and IBM are teaming up to develop new technology that could push the cost of genomic sequencing to as low as $100. Roche will fund research at IBM as its subsidiary 454 Life Sciences
The big genome payday is still years away
Even as the first drugs developed from genomic studies are registering on the market, with some blockbusters like denosumab and Benlysta likely to capture huge markets, there are still plenty of
